Authors: Agelink, MW Zeit, T Baumann, B Majewski, T Lemmer, W Postert, T Lukas, K Klieser, E

Citation: Mw. Agelink et al., In vivo cardiovascular effects of the new atypical neuroleptic sertindole, INT J PSYC, 5(1), 2001, pp. 33-40

Authors: Agelink, MW Malessa, R Baumann, B Majewski, T Akila, F Zeit, T Ziegler, D

Citation: Mw. Agelink et al., Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate, CLIN AUTON, 11(2), 2001, pp. 99-108

Authors: Agelink, MW Andrich, J Postert, T Wurzinger, U Zeit, T Klotz, P Przuntek, H

Citation: Mw. Agelink et al., Relation between electro convulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100, J NE NE PSY, 71(3), 2001, pp. 394-396

Authors: Agelink, MW Ullrich, H Lemmer, W Dirkes-Kersting, A Zeit, T

Citation: Mw. Agelink et al., Screening for concomitant alcohol abuse in schizophrenia: Clinical significance of the Munich alcoholism test and laboratory tests, EUR ADDIC R, 5(2), 1999, pp. 82-87

Authors: Agelink, MW Lemmer, W Malessa, R Zeit, T Majewski, T Klieser, E

Citation: Mw. Agelink et al., Improved autonomic neurocardial balance in short-term abstinent alcoholicstreated with acamprosate, ALC ALCOHOL, 33(6), 1998, pp. 602-605

Authors: Agelink, MW Malessa, R Weisser, U Lemmer, W Zeit, T Majewski, T Klieser, E

Citation: Mw. Agelink et al., Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN), J NEUR SCI, 161(2), 1998, pp. 135-142